Systemic meglumine antimoniate-induced severe dilated cardiomyopathy

Dermatol Ther. 2022 Dec;35(12):e15896. doi: 10.1111/dth.15896. Epub 2022 Oct 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiprotozoal Agents*
  • Cardiomyopathy, Dilated* / chemically induced
  • Cardiomyopathy, Dilated* / drug therapy
  • Humans
  • Leishmaniasis, Cutaneous* / diagnosis
  • Leishmaniasis, Cutaneous* / drug therapy
  • Meglumine / adverse effects
  • Meglumine Antimoniate / adverse effects
  • Organometallic Compounds*

Substances

  • Meglumine Antimoniate
  • Meglumine
  • Antiprotozoal Agents
  • Organometallic Compounds